Growth hormone-insuline-like growth factor-I system in pejerrey Odontesthes bonariensis (Atheriniformes)

• Autor(a) principal: Arranz,S.E.
• Data de Publicação: 2008
• Outros Autores: Sciara,A. A., Botta,P., Cerutti,P., Tobin,M., Somoza,G.M.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista Brasileira de Zootecnia (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-35982008001300001
• topic: growth; growth hormone; muscle hypertrophy; oral administration; recombinant protein

Using biotechnology to increase the growth rates of fish is likely to reduce production costs per unit of food. Among vertebrates, fish appear to occupy a unique position, when growth patterns are considered. With few exceptions, fish species tend to grow indeterminately, implying that size is never fixed. Both hyperplasia and hypertrophy contribute to post-larval muscle growth in fish. Growth hormone (GH) - Insulin-like Growth Factor I (IGF-I) is the most important growth axis in fish. Our experimental model, the pejerrey, Odontesthes bonariensis (Ateriniformes) is a South American inland water fish considered to be a promising species for intensive aquaculture. However, one major drawback to achieve this goal is its slow growth in captivity. In order to understand how growth is regulated in this species, our first objective was to characterized pejerrey GH- IGF-I axis. We first cloned and characterized pejerrey (pj) GH, IGF-I and the growth hormone receptors (GHRs) I and II. In addition to providing valuable data for evolutionary comparison of GH, investigation of GH action in teleosts is particularly important because of its potential application in aquaculture. GH can not only promote the somatic growth in fish but also lower dietary protein requirements. A prerequisite for providing sufficient amounts of GH for basic research and aquaculture application is a large-scale production of GH. For that purpose, recombinant pjGH was expressed in a bacterial system. Protocols for solubilization and proper folding were achieved. Activity of recombinant pjGH was assessed in fish by measuring the liver IGF-I response to different doses of GH. IGF-I transcript was measured in the liver after pjGHr in vivo stimulation by means of quantitative real-time PCR assays. A dose-dependent response of IGF-I mRNA was observed after pjGHr administration, and reached a 6 fold IGF-I maximum increase over control group when 2.5 µg pjGH /g-body weight were injected. Temporal analysis of hepatic IGF-I mRNA levels showed that administration of a single dose of pjGHr into juvenile pejerrey resulted in a significant increase (P<0.02) 9 hours post injection. These results demonstrates that recombinant pjGH could promote a dramatic response in liver, increasing the IGF-I mRNA level. We also study the effect of GH on muscle growth after oral administration. A significant association between GH doses and mean fiber area (MFA) was observed even with a caloric restrictive diet. MFA increased 3.7 µm² per each unit of GH supplied indicating that GH promoted white muscle hypertrophy. These preliminary data indicates that GH could be absorbed by the intestine in an active form and promote somatic growth.